Menlo Therapeutics hits high end of boosted IPO range, raises $119M
January 25, 2018 at 10:03 AM EST
It is the first of two Bay Area IPOs expected this week, with another Redwood City biotech — ARMO Biosciences Inc. — expected to make its Wall Street debut on Friday. ARMO hopes to raise up to $122.7 million.
